A femoral trial is the curved convex head at the end of the thigh bone that fits into the socket of the hip. Artificial femoral trials are used to replace the damaged head or loss of trial femoral heads in soft tissues after hip replacement surgery.The global femoral trial market is primarily driven by the growing number of orthopedic surgeries owing to an increases in risk factors such as obesity, sedentary lifestyle, malabsorption, trauma, and poor diet, among others. The growing prevalence of diseases, such as osteoarthritis and early menopause, affects structure and bone density, which increases the propensity of fractures. According to Centers for Disease Control and Prevention, osteoarthritis affects over 30 million adults in the U.S.
Technological advancements in femoral trial technology, such as the development of advanced bearing materials that include antioxidant-infused polyethylene & coatings to combat surgical trauma, friction, and others, are contributing to the faster adoption of femoral trials. Improvements in surgical techniques and the development of real-time diagnostic imaging, such as computed tomography and magnetic resonance imaging, among others, have boosted the number of procedures performed. The global femoral trial market is increasingly inclined toward minimally invasive surgery owing to its lower footprint. This trend has been encouraged by the advent of computer-assisted surgery and robotic surgery. Growth in the number of customizations based on the individual anatomy of a patient or in case of difficult reconstructive surgeries are also among factors driving the adoption of femoral trials.
However, the global femoral trial market is being hampered by the high cost of the procedure, risk of infection, implant failure, thrombosis, implant rejection, osteolysis, and lack of trained manpower & specialty hospitals. Moreover, the average cost of surgery is approximately USD 50,000 in the U.S., however, there the prices vary largely in different states. The cost in Alabama is the lowest.
Request for Sample Report @ https://www.persistencemarketresearch.com/samples/24079
Femoral trial Market: Segmentation
The global femoral trial market is segmented based on material of construction, cementing technique, sex, end users, and region.
Based on material of construction, the global femoral trial market is segmented into:
- Metal Femoral Trial
- Stainless Steel
- Nickel titanium
- Cobalt Chromium
- Polymer Femoral Trial
Based on cementing technique, the global patellar implant market is segmented into:
- Cement less
Based on sex, the global patellar implant market is segmented into:
Based on end users, the global patellar implant market is segmented into:
Market Trends: Overview
Metal hypersensitivity and toxicity, which affects about 10 to 15% of the population, is driving the femoral trial market toward the adoption of inert femoral trial materials such as polyethylene. The U.S. FDA in 2011 issued an advisory on metal implants, which necessitated clinical trials and postmarket studies for metal implants before they are released in the market.
Request for view TOC @ https://www.persistencemarketresearch.com/toc/24079
Some of the major players operating in the global femoral trial market are Stryker, Sharma Orthopedic India Pvt. Ltd., DePuy Synthes (Johnson & Johnson), Zimmer Biomet, and Baumer Holding AG.